Brokers Issue Forecasts for IDEX's Q1 Earnings (NYSE:IEX)
Zacks Research has updated its Q1 2027 EPS estimates for IDEX (NYSE:IEX) to $2.07, raising it from $2.00, and also boosted longer-term forecasts for fiscal years 2027 and 2028. This follows IDEX's recent earnings beat, where the company reported $2.00 EPS against a $1.78 consensus, with an 8.9% year-over-year revenue increase. Despite a "Moderate Buy" consensus rating and a $240.22 average target price, the stock recently traded down 1.3%, and the CEO sold a significant number of shares.
IDEX Corporation stock (US45167R1041): Earnings momentum and dividend hike keep industrial player in focus
IDEX Corporation shares are trading near record levels after reporting strong first-quarter results that surpassed market expectations, leading analysts to raise earnings estimates. The company also announced a dividend increase, signaling confidence in its future earnings power and cash flow. This positive momentum, driven by its focus on specialized, high-margin industrial components and diversified markets, has resulted in double-digit stock gains year-to-date and a "Moderate Buy" consensus rating from analysts.
IDEX Corp. stock underperforms Thursday when compared to competitors
Shares of IDEX Corp. (IEX) fell 1.24% on Thursday, closing at $205.61, despite a positive trading session for the broader stock market. The S&P 500 Index and Dow Jones Industrial Average both saw gains. The stock is currently 8.15% below its 52-week high of $223.85, which was reached on April 29th.
Idex Corporation Lifts 2026 Outlook After Strong Q1
Idex Corporation has raised its full-year 2026 organic growth target to 3%-4% and increased its adjusted EPS outlook after delivering stronger-than-expected Q1 results. The upward revision is primarily driven by robust performance in its Health & Science Technologies segment, which is experiencing strong demand from sectors like data centers and semiconductors. Despite some softness in other segments and a dip in gross margin due to mix, the company maintains a positive multi-year outlook supported by a growing backlog and strategic acquisitions.
Idex Corporation Lifts 2026 Outlook After Strong Q1
Idex Corporation reported better-than-expected Q1 results, leading them to raise their full-year 2026 organic growth target to 3%-4%. The company's Health & Science Technologies segment was a key driver of outperformance, offsetting softness in other areas. Idex also increased its 2026 adjusted EPS outlook and plans to continue share repurchases and strategic acquisitions.
IDEX Corporation stock (US45167R1041): dividend and upbeat 2026 outlook keep industrial specialist in focus
IDEX Corporation confirmed its regular quarterly cash dividend and tightened/lifted parts of its 2026 outlook after a strong first quarter. The company, a diversified industrial technology group, is known for its focus on mission-critical components in various sectors and its strategy of growth through acquisitions and disciplined capital allocation, including dividends and share repurchases. Its stock has shown notable gains over the past year, reflecting investor confidence in its specialized market positioning and steady returns.
IDEX Corporation stock (US45167R1041): Latest catalyst in focus
IDEX Corporation is gaining attention from U.S. investors due to its diverse portfolio in industrial manufacturing, which benefits from capital spending, water infrastructure, and automation trends. The company's business model, focused on engineered components, fluid, and metering technologies, positions it well within manufacturing cycles and recurring aftermarket demand. Its relevance to investors stems from its role as a proxy for manufacturing confidence and its exposure to long-term capital expenditure cycles in the U.S.
Idex Corporation Lifts 2026 Outlook After Strong Q1
Idex Corporation reported better-than-expected Q1 results and raised its full-year 2026 outlook, driven by strong order momentum and expanding margins, particularly in its Health & Science Technologies segment. The company increased its 2026 organic growth target to 3%-4% and adjusted EPS range to $8.35-$8.55, reflecting confidence in its multi-year growth runway despite some softness in Fluid & Metering Technologies and life sciences markets. Idex also continues its balanced capital allocation strategy, including share repurchases, dividends, and bolt-on acquisitions.
IDEX Corporation stock (US45167R1041): Dividend, price action, and industrial exposure
IDEX Corporation shares closed higher on May 18, 2026, with investors focusing on the company's dividend profile and its exposure to industrial end-markets. IDEX is a diversified industrial manufacturer specializing in highly engineered products for fluid handling, medical and life sciences, and industrial processing systems. The company offers a steady dividend and provides investors with exposure to various industrial sectors, making it relevant for those interested in industrial demand tied to manufacturing, water infrastructure, and healthcare equipment.
IDEX Corp. stock underperforms Tuesday when compared to competitors
Shares of IDEX Corp. (IEX) fell 1.67% to $205.15 on Tuesday, performing worse than the broader stock market, which also saw declines in the S&P 500 Index and the Dow Jones Industrial Average. The company's stock closed 8.35% below its 52-week high.
Tredje AP fonden Boosts Stock Holdings in IDEX Corporation $IEX
Tredje AP fonden significantly increased its stake in IDEX Corporation by 892.1% in the fourth quarter, now owning 104,878 shares valued at $18.7 million. Wall Street analysts have a generally positive outlook on IEX, rating it as a "Moderate Buy" with a consensus target price of $240.22. The company recently reported strong quarterly results, beating EPS and revenue estimates, and increased its dividend to $0.73 per share.
Gabelli Funds LLC Has $32.23 Million Stock Position in IDEX Corporation $IEX
Gabelli Funds LLC reduced its stake in IDEX Corporation by 5.1% in Q4, now holding 181,100 shares valued at $32.23 million. IDEX reported stronger-than-expected Q1 earnings of $2.00 per share and revenue of $886.9 million, prompting a dividend increase to $0.73 per share and a "Moderate Buy" consensus rating from analysts. Insider selling by CEO Eric D. Ashleman was also noted, alongside IDEX's financial metrics and future guidance.
IDEX Corporation stock (US45167R1041): institutional buying and S&P 500 player in engineered industr
IDEX Corporation (IEX) has seen increased institutional interest, with New York Life Investment Management significantly boosting its stake. The S&P 500 component, trading above $200, specializes in highly engineered industrial products, particularly fluidics systems, measurement technologies, and safety solutions for critical applications. Its focus on niche technologies and recurring aftermarket business provides stable cash flows, positioning it as a specialized industrial technology provider rather than a broad capital goods conglomerate.
nLIGHT, Dollar Tree, and IDEX: Cash Generators with Growth Concerns - News and Statistics
StockStory identifies three cash-generating companies—nLIGHT (NASDAQ:LASR), Dollar Tree (NASDAQ:DLTR), and IDEX (NYSE:IEX)—that face challenges in sustainable growth despite their positive free cash flow. nLIGHT shows slower revenue growth and operating margin losses, Dollar Tree experiences declining sales and low return on invested capital, and IDEX lacks organic revenue growth, relying on acquisitions. These examples highlight that cash generation alone does not guarantee a successful growth trajectory, suggesting alternative investments for those seeking robust expansion.
Bank Julius Baer & Co. Ltd Zurich Has $214,000 Position in IDEX Corporation $IEX
Bank Julius Baer & Co. Ltd Zurich significantly reduced its stake in IDEX Corporation by 91.3% in the fourth quarter, leaving it with 1,200 shares valued at $214,000. Despite this reduction, IDEX reported strong Q1 results, exceeding analyst expectations for EPS and revenue, and raised its full-year guidance. Analysts maintain a "Moderate Buy" consensus rating with a price target of $240.22, and the company recently increased its quarterly dividend.
IDEX declares $0.71 dividend
IDEX has declared a quarterly dividend of $0.71 per share. This financial move provides income to shareholders and is scheduled for an unspecified payment date.
IDEX declares $0.71 dividend
The short article states that IDEX has declared a dividend of $0.71. No further details are provided regarding the dividend or the company.
IDEX Corporation stock (US45167R1041): Q1 2026 results put niche industrial player back in focus
IDEX Corporation has reported strong Q1 2026 earnings and refined its full-year outlook, drawing investor attention to the specialized industrial group. The company focuses on fluid and fire-safety technologies, operating a diversified business model with key revenue drivers in fluid handling, health & science, and fire & safety products. Its strategy involves acquiring specialized businesses and emphasizing innovation and cost control to maintain strong margins and investor interest.
Lowe's Companies Among 7 Companies To Announce Dividend Increases In The Second Half Of May
Lowe's Companies is expected to announce its 64th consecutive annual dividend increase in late May, despite facing EPS stagnation. The dividend growth is predicted to be between 3.3% and 4.2%, with a forward yield around 2.27%–2.29%. Other companies like Donaldson Company are also anticipated to announce dividend increases, while Flowers Foods faces challenges regarding its payout sustainability due to declining earnings.
IDEX Corporation stock (US45167R1041): dividend continuity after strong Q1 earnings surprise
IDEX Corporation has sustained its dividend streak and outperformed Q1 earnings expectations, reporting $2.07 per share against an estimated $1.99. The company announced a regular cash dividend of $0.73 per share payable on June 5, 2026, marking its 126th consecutive dividend. IDEX, an industrial engineering specialist, attributes its resilience to its focus on mission-critical components across industrial, health, and safety sectors, supported by strategic acquisitions and a strong market position.
IDEX Corp. stock outperforms competitors despite losses on the day
Shares of IDEX Corp. (IEX) fell 1.75% to $207.69 on Friday, marking its fifth consecutive day of losses. Despite this decline, the stock still outperformed the broader market, as the S&P 500 Index (SPX) dropped 1.24% and the Dow Jones Industrial Average (DJIA) fell 1.07% on the same day.
Wellington Management holds 2.34% of IDEX (IEX) in Schedule 13G/A
Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G/A, reporting a 2.34% beneficial ownership stake in IDEX Corporation (IEX). The filing indicates shared dispositive power over 1,738,531 shares and shared voting power over 1,597,417 shares as of March 31, 2026. These shares are held of record by clients of Wellington's investment advisers, signifying a passive investment.
IEX: Dividend Strength And Buybacks Will Support Returns Going Forward
AnalystConsensusTarget has updated its price target for IDEX to $237.71 based on revised revenue growth, profit margins, and future P/E assumptions. IDEX recently approved a quarterly cash dividend of $0.73 per share and repurchased 481,165 shares for $96.8 million this year. Management indicates a focus on bolt-on M&A and continued share repurchases, with the valuation changes reflecting an increased fair value and higher revenue growth assumptions.
IDEX Corporation stock (US45167R1041): earnings beat, higher dividend and guidance lift investor focus
IDEX Corporation reported stronger-than-expected quarterly results, increased its dividend, and provided optimistic guidance for 2026, drawing significant investor attention. The company specializes in highly engineered industrial products across various sectors. Analysts maintain a "Moderate Buy" rating, although insider selling and broader economic trends warrant investor monitoring.
IDEX Corporation $IEX Shares Purchased by Baader Bank Aktiengesellschaft
Baader Bank Aktiengesellschaft significantly increased its stake in IDEX Corporation, adding 6,000 shares to own a total of 27,809 shares valued at approximately $4.95 million. This move follows IDEX's strong quarterly results, beating EPS and revenue estimates, and providing optimistic guidance for Q2 and full-year 2026. The company also raised its quarterly dividend, and analysts maintain a "Moderate Buy" rating with an average price target of $234.70.
IDEX Corp(IEX.US) Officer Sells US$3.31 Million in Common Stock
An officer at IDEX Corp (IEX.US) has sold common stock valued at US$3.31 million. This transaction indicates a significant insider sale at the company.
Insider Sell: Eric Ashleman Sells Shares of IDEX Corp (IEX)
Eric Ashleman, CEO and President of IDEX Corp (IEX), sold 15,385 shares of the company on May 11, 2026, and now holds 66,658 shares. This transaction is part of a pattern where Ashleman has only sold shares (totaling 15,385) over the past year, with no purchases. IDEX Corp's stock was trading at $215.22, with a market cap of $15.707 billion, and is considered fairly valued based on its GF Value.
Idex Insider Sold Shares Worth $3,311,195, According to a Recent SEC Filing
An insider at Idex Corporation sold shares valued at $3,311,195, as disclosed in a recent SEC filing. This transaction aligns with the company's policy requiring officers and directors to retain a significant portion of their stock, indicating the sale was likely part of a planned financial strategy rather than a reflection of negative corporate outlook. The stock has experienced a year-to-date gain, outperforming the S&P 500.
IDEX (IEX) CEO Ashleman exercises options, sells 15,385 common shares
IDEX Corp CEO Eric D. Ashleman exercised options for 15,385 common shares at $93.27 each on May 11, 2026. The same day, he sold all 15,385 shares in two open-market transactions at weighted average prices of $215.8115 and $214.9457 per share. Following these transactions, Ashleman directly owned 66,658 shares of IDEX common stock.
Idex Insider Sold Shares Worth $3,311,195, According to a Recent SEC Filing
An insider at Idex Corporation (IEX) recently sold shares valued at $3,311,195, according to a new SEC filing. The article highlights this insider transaction and provides a brief overview of Idex Corporation's business, which includes fluidic systems, flow meters, and fire monitoring systems. It also lists recent news and analyst ratings concerning the company.
IDEX Corporation stock (US45167R1041): Dividend Raised Amid Strong Q1 Results
IDEX Corporation reported strong Q1 results and announced its 126th consecutive quarterly dividend increase to $0.73 per share, payable on June 5, 2026. The company, trading on Nasdaq under IEX, specializes in fluid handling technologies and industrial equipment, serving markets like water treatment and life sciences. This financial health and diversified industrial exposure, coupled with its dividend aristocrat status, make it an attractive option for US investors.
IDEX Corporation stock (US45167R1041): Trading at $213.85 amid steady market position
IDEX Corporation (IEX) shares are trading at $213.85 on the NYSE, experiencing a minor decline of 0.07%. The company, known for its engineered solutions in fluid and metering technologies, health and science, and fire and safety equipment, maintains a steady market position supported by its diversified portfolio. Investors are watching for upcoming Q2 earnings, projected to show EPS growth.
Is IDEX Corporation (IEX) A Good Stock To Buy Now?
IDEX Corporation (IEX) is being considered a good stock to buy due to its position as a diversified industrial manufacturer with a focus on high-margin products and strong free cash flow generation. The company, which trades at $214.93, is expected to see an inflection in operating performance and has a fair value estimated around $235 per share, driven by sustained mid-single-digit organic growth and strategic acquisitions. Despite being exposed to cyclical markets, its niche positioning and diversified customer base provide resilience, though IDEX is not among the 40 most popular stocks among hedge funds, with 37 funds holding positions in the last quarter.
What Is IDEX Corporation's (NYSE:IEX) Share Price Doing?
This article analyzes IDEX Corporation's share price performance, highlighting a 32% decline over the past three months and a 17% drop over the last year. It discusses key financial metrics like earnings per share (EPS) growth, return on equity (ROE), and debt-to-equity ratios. The analysis suggests that while IDEX has shown strong potential, its current valuation might be influenced by a decline in market sentiment.
Stifel Nicolaus Remains a Buy on Contineum Therapeutics, Inc. Class A (CTNM)
Stifel Nicolaus analyst Paul Matteis has reiterated a Buy rating for Contineum Therapeutics, Inc. Class A (CTNM), setting a price target of $28.00. This recommendation comes despite the company reporting a quarterly GAAP net loss of $14.46 million, an improvement from the prior year. The analyst consensus for CTNM is a Strong Buy, with an average price target suggesting a significant upside.
IDEX Corporation stock (US45167R1041): Drops 1.35% to $213.99
IDEX Corporation's stock dropped 1.35% to $213.99 on May 11, 2026, following its Q1 results declaration in April and a quarterly dividend announcement. The company, an industrial firm specializing in fluid technologies, operates through three segments and focuses on engineered solutions for industrial, fire & safety, and life science markets. Its stock performance and corporate updates are influenced by broader sector trends and its strong market position.
73 Workers Losing Jobs As Bristol Manufacturing Plant Closes
IDEX Health & Science LLC announced it will close its manufacturing plant in Bristol, Connecticut, leading to the layoff of 73 workers. The layoffs will occur in two phases, starting July 15 and concluding by November 13, permanently ceasing all operations at the facility. This closure adds to the ongoing trend of manufacturing job losses in Connecticut, following a similar announcement by Stanley Black & Decker.
73 Workers Losing Jobs As CT Manufacturing Plant Closes
IDEX Health & Science LLC is closing its manufacturing plant in Bristol, Connecticut, leading to 73 job losses. The layoffs will occur in two rounds, starting in July and concluding by November, permanently ceasing all operations at the facility. This closure adds to a trend of manufacturing job losses in Connecticut, following a similar announcement by Stanley Black & Decker.
[144] IDEX CORP /DE/ SEC Filing
This SEC filing (Form 144) for IDEX CORP /DE/ details a proposed sale of 15,385 common shares with an aggregate market value of $3,311,194.99 on the NYSE. The shares were acquired through a stock option exercise on May 11, 2026. The document confirms no securities were sold during the past three months by the person filing this notice.
IDEX Corp. stock underperforms Monday when compared to competitors
IDEX Corp. stock (IEX) fell by 1.34% to $214.01 on Monday, contrary to the overall favorable market trend where the S&P 500 Index and Dow Jones Industrial Average both saw gains. The company's stock closed 4.39% below its 52-week high of $223.85, which was reached on April 29th.
IDEX Corporation stock (US45167R1041): Q1 earnings beat lifts shares
IDEX Corporation reported strong Q1 2026 earnings, beating EPS estimates with $2.00 versus $1.78 expected, and achieving revenue of $886.9 million. The company provided full-year EPS guidance of $8.35-$8.55, reflecting confidence in its diversified industrial business model. Its focus on specialized products in Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products, along with benefits from US infrastructure spending, positions it well for continued growth.
IDEX 1Q Sales $886.9M >IEX
IDEX reported first-quarter sales of $886.9 million. This financial update provides key sales figures for the company's performance during the quarter.
IDEX Corporation stock (US45167R1041): Strong Q1 earnings and 126th straight dividend
IDEX Corporation reported robust Q1 2026 results, with sales reaching $886.9 million and net income at $120 million, significantly beating earnings estimates. The company also declared its 126th consecutive quarterly dividend of $0.73 per share, underscoring its financial stability and commitment to shareholder returns. Specializing in precision components across various industrial sectors, IDEX leverages its engineering expertise and strategic acquisitions to drive growth in niche markets globally.
Precision Trading with Idex Corporation (IEX) Risk Zones
This article analyzes Idex Corporation (IEX) with a neutral near-term sentiment but strong mid and long-term prospects. It provides specific AI-generated trading strategies including position trading, momentum breakout, and risk hedging, complete with entry zones, targets, and stop losses. The analysis also details multi-timeframe signal strengths, support, and resistance levels for IEX.
Mitsubishi UFJ Asset Management Co. Ltd. Grows Holdings in IDEX Corporation $IEX
Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in IDEX Corporation by 4.5% in the fourth quarter, bringing its total to 160,520 shares valued at approximately $28.7 million. IDEX exceeded quarterly earnings expectations with adjusted EPS of $2.00 and revenue of $886.9 million, and also raised its quarterly dividend to $0.73 per share. Institutional investors collectively own 97.96% of IDEX's stock, and analysts currently have a "Moderate Buy" rating with an average target price of $234.70.
The Bull Case For IDEX (IEX) Could Change Following Strong Q1 Results And 126th Straight Dividend
IDEX Corporation recently announced a quarterly cash dividend of US$0.73 per share and strong first-quarter 2026 results with US$886.9 million in sales and US$120 million in net income. This performance, along with consistent shareholder returns through dividends and share repurchases, could reframe the investment narrative for IDEX, particularly concerning growth, margins, and capital allocation. The company's focus on cost savings and high-value applications appears to be supporting margins despite soft demand in some sectors, potentially influencing its projected fair value and future prospects.
IDEX Shareholders Back Board, Executive Pay and Auditor
IDEX Corporation's shareholders recently held their Annual Meeting, re-electing four Class I directors, approving executive compensation on an advisory basis, and ratifying Deloitte & Touche LLP as the independent auditor for 2026. These outcomes demonstrate strong investor confidence in the company's leadership, governance, and financial reporting. Analysts maintain a "Buy" rating on IEX stock with a $250.00 price target, and TipRanks’ AI Analyst indicates an "Outperform" rating, citing solid financial fundamentals and a positive technical uptrend.
IDEX Corporation stock (US45167R1041): Quarterly dividend declared for June 2026 payment
IDEX Corporation has declared its 126th consecutive quarterly cash dividend of $0.73 per share, payable on June 5, 2026, to shareholders of record as of May 22, 2026. The company, a diversified industrial machinery business listed on the NYSE, operates in industrial, fire and safety, life science, and water markets. This dividend declaration highlights IDEX's commitment to returning capital to shareholders and its consistent payout history.
IDEX Corporation (NYSE:IEX) Given Average Rating of "Moderate Buy" by Analysts
IDEX Corporation (NYSE:IEX) has received an average rating of "Moderate Buy" from analysts, with a consensus twelve-month price objective of $234.70. The company recently reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend. Institutional investors hold a significant portion of its stock.
[Form 4] IDEX CORP /DE/ Insider Trading Activity
An IDEX Corp. director, Watts Stanfield Paris, received an equity award of 805 restricted stock units (RSUs) on May 6, 2026. These RSUs represent a contingent right to receive one share of IDEX common stock each, vesting in full on the earlier of May 6, 2027, or the date of IDEX’s next annual stockholders meeting, subject to continuous service. Following this grant, the director holds 4,195 shares of common stock.
